In a House-Senate conference committee agreement on Zika virus emergency funding reached late June 22, lawmakers agreed to provide $1.1bn in funds to fight the virus to the National Institutes of Health and several other agencies, but not FDA, which is charged with safety and effectiveness reviews of diagnostics and vaccines.
The Zika Response Appropriations Act is part of the 2017 Military Construction/VA Appropriations bill. The final conference report, House Report 114-640, was agreed to by the House, but still requires a "yes" vote in the Senate
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?